AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21475006 — intervention group
Group type: COMPARATOR
Intervention: Cadaveric allograft (standard of care)
Number of subjects: 15
Study 19057981 — intervention group
Group type: EXPERIMENTAL
Intervention: Active LLLT (830 nm wavelength, 100 mW, spot size 0.0028 cm(2), 3‐4 J per point)
Number of subjects: 20
Study 19057981 — intervention group
Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 20
Study 16510331 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral prophylactic salpingo‐oophorectomy (BPSO)
Number of subjects: 666
Study 15120887 — intervention group
Group type: EXPERIMENTAL
Intervention: OPCAB
Number of subjects: 401
Study 15120887 — intervention group
Group type: COMPARATOR
Intervention: CABG-CPB
Number of subjects: 401
Study 15120887 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 401
Study 12066422 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpretation of target symbols (e.g., interpreting '>' as a right-pointing arrow or as a headlight shining to the left)
Number of subjects: 0
Study 12066422 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of target presentation during response planning or execution
Number of subjects: 0
Study 9800669 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG/hCG therapy
Number of subjects: 97
Study 9800669 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 97
Study 7624530 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery temperature measurement
Number of subjects: 32
Study 7624530 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanic temperature measurement
Number of subjects: 32
Study 7624530 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral temperature measurement
Number of subjects: 32
Study 7624530 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary temperature measurement
Number of subjects: 32
Study 2515625 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (40 mg/kg), 10 weeks after treatment
Number of subjects: 20
Study 2515625 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (40 mg/kg), 6 weeks after treatment
Number of subjects: 20
Study 2515625 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (double dose of 40 mg/kg), within 10 days after treatment
Number of subjects: 20
Study 2515625 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 20
Study 78718 — intervention group
Group type: EXPERIMENTAL
Intervention: Triprolidine (2.5 mg)
Number of subjects: 10
Study 78718 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine (60 mg)
Number of subjects: 10
Study 78718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30519751 — intervention group
Group type: EXPERIMENTAL
Intervention: First-trimester combined screening (FTCS)
Number of subjects: 688
Study 30519751 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound plus cfDNA-based approach (US-cfDNA)
Number of subjects: 688
Study 30519751 — intervention group
Group type: COMPARATOR
Intervention: Overall screening for trisomies 18 and 13
Number of subjects: 688
Study 28606735 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg twice daily
Number of subjects: 75
Study 28606735 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg daily
Number of subjects: 75
Study 25863535 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose optimization preoperatively
Number of subjects: 69
Study 25863535 — intervention group
Group type: COMPARATOR
Intervention: No optimization preoperatively
Number of subjects: 69
Study 25863535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose management postoperatively
Number of subjects: 69
Study 25863535 — intervention group
Group type: COMPARATOR
Intervention: Conservative glucose management postoperatively
Number of subjects: 69
Study 23690197 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric diet
Number of subjects: 100
Study 23690197 — intervention group
Group type: COMPARATOR
Intervention: No diet (Control)
Number of subjects: 100
Study 21557884 — intervention group
Group type: EXPERIMENTAL
Intervention: Active high-frequency rTMS (10 Hz at 110% of motor threshold, 1 session/day for 6 weeks)
Number of subjects: 30
Study 21557884 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study 21557884 — intervention group
Group type: EXPERIMENTAL
Intervention: Active high-frequency rTMS
Number of subjects: 30
Study 19729401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with treatment intensification
Number of subjects: 1283
Study 19729401 — intervention group
Group type: COMPARATOR
Intervention: Control group with treatment intensification
Number of subjects: 1283
Study 19729401 — intervention group
Group type: COMPARATOR
Intervention: Control group with BP levels above target
Number of subjects: 1283
Study 19729401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with BP levels above target
Number of subjects: 1283
Study 19729401 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients managed by practice nurse
Number of subjects: 1283
Study 19729401 — intervention group
Group type: EXPERIMENTAL
Intervention: Both study groups with proper treatment intensification
Number of subjects: 1283
Study 17250690 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-oxidant supplement (beta-carotene 9 mg/day, vitamin C 1500 mg/day, vitamin E 130 mg/day, zinc 45 mg/day, selenium 76 microg/day, garlic 150 mg/day)
Number of subjects: 54
Study 17250690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 15180224 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-interval exercise program
Number of subjects: 14
Study 15180224 — intervention group
Group type: COMPARATOR
Intervention: General rehabilitation program (Control)
Number of subjects: 14
Study 11503466 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of the SFJ with resorbable Vicryl
Number of subjects: 400
Study 11503466 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation with Vicryl and continuous non‐resorbable stitching over (Prolene) the saphenous stump
Number of subjects: 400
Study 11503466 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐resorbable ligation of the SFJ (Ethibond)
Number of subjects: 400
Study 11503466 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethibond ligation with Prolene stitching over the saphenous stump
Number of subjects: 400
Study 9754182 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cyclosporin A (CsA) 2% in maize oil
Number of subjects: 21
Study 29317666 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 0.1 mg/m2
Number of subjects: 32
Study 29317666 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 0.3 mg/m2
Number of subjects: 32
Study 29317666 — intervention group
Group type: COMPARATOR
Intervention: Proposed biosimilar 0.3 mg/m2
Number of subjects: 32
Study 29317666 — intervention group
Group type: COMPARATOR
Intervention: Reference product 0.3 mg/m2
Number of subjects: 32
Study 29317666 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 1 mg/m2
Number of subjects: 32
Study 28424854 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Enhancement and Cognitive Therapy (NECT) as an add-on to treatment as usual
Number of subjects: 106
Study 28424854 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 106
Study 28424854 — intervention group
Group type: EXPERIMENTAL
Intervention: NECT
Number of subjects: 106
Study 25532686 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet computer
Number of subjects: 223
Study 25532686 — intervention group
Group type: COMPARATOR
Intervention: Paper
Number of subjects: 223
Study 24217237 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler ultrasonography (USG) mapping (Group B)
Number of subjects: 314
Study 24217237 — intervention group
Group type: COMPARATOR
Intervention: Classical methods (Group A)
Number of subjects: 314
Study 19299763 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative BNP elevation > or =50 pg/mL
Number of subjects: 133
Study 19299763 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of preoperative BNP elevation > or =50 pg/mL and postoperative cTn I elevation > or =2 ng/mL
Number of subjects: 133
Study 19299763 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal preoperative BNP value
Number of subjects: 133
Study 17560916 — intervention group
Group type: EXPERIMENTAL
Intervention: WISE-MD modules
Number of subjects: 0
Study 17560916 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching methods
Number of subjects: 0
Study 15470798 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 36
Study 15470798 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 36
Study 15470798 — intervention group
Group type: COMPARATOR
Intervention: Reboxetine and Citalopram
Number of subjects: 36
Study 11166379 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapies aimed at inhibiting lymphoid cell apoptosis
Number of subjects: 0
Study 11166379 — intervention group
Group type: COMPARATOR
Intervention: Anti-cytokine and anti-inflammatory therapies
Number of subjects: 0
Study 10335042 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation (R)
Number of subjects: 46
Study 10335042 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 46
Study 8573926 — intervention group
Group type: EXPERIMENTAL
Intervention: Moist toilet paper preparation
Number of subjects: 40
Study 8573926 — intervention group
Group type: EXPERIMENTAL
Intervention: Recycled toilet paper preparation
Number of subjects: 40
Study 8573926 — intervention group
Group type: COMPARATOR
Intervention: Conventional toilet paper preparation
Number of subjects: 40
Study 2561015 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg per os)
Number of subjects: 6
Study 2561015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 861108 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium nitroprusside
Number of subjects: 45
Study 861108 — intervention group
Group type: EXPERIMENTAL
Intervention: trimetaphan
Number of subjects: 45
Study 30982604 — intervention group
Group type: EXPERIMENTAL
Intervention: Low total testosterone (TT <264 ng/dL)
Number of subjects: 781
Study 30982604 — intervention group
Group type: COMPARATOR
Intervention: Normal total testosterone (TT > 264 ng/dL)
Number of subjects: 781
Study 26927283 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin treatment
Number of subjects: 150
Study 26927283 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model including INSIG1 expression level and splicing changes
Number of subjects: 150
Study 25452062 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation medication
Number of subjects: 124
Study 25452062 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation group therapy
Number of subjects: 124
Study 23591657 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid medications
Number of subjects: 1062
Study 23591657 — intervention group
Group type: COMPARATOR
Intervention: Nonopioid medications
Number of subjects: 1062
Study 21692408 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg + Dexamethasone 4 mg
Number of subjects: 105
Study 21692408 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg + Dexamethasone 8 mg
Number of subjects: 105
Study 21692408 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution
Number of subjects: 105
Study 19491220 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human GH (2 mg/d sc; n = 22)
Number of subjects: 30
Study 19491220 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 8)
Number of subjects: 30
Study 17326082 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose (D(D)) Gd-DTPA
Number of subjects: 11
Study 17326082 — intervention group
Group type: COMPARATOR
Intervention: Single-dose (D(S)) Gd-DTPA
Number of subjects: 11
Study 15075538 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 immunotherapy with HAART
Number of subjects: 15
Study 15075538 — intervention group
Group type: COMPARATOR
Intervention: HAART alone
Number of subjects: 15
Study 11465233 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA)
Number of subjects: 121
Study 11465233 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated patients)
Number of subjects: 121
Study 11465233 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA
Number of subjects: 121
Study 9571515 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers (n=467)
Number of subjects: 1341
Study 9571515 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers (n=874)
Number of subjects: 1341
Study 7919965 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy with IFN-alpha and IL-2
Number of subjects: 72
Study 7919965 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery or chemotherapy)
Number of subjects: 72
Study 3290263 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 5 mg twice a day
Number of subjects: 20
Study 31319002 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 307318
Study 31319002 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 307318
Study 30171747 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metformin monotherapy (HMET) 1,500 mg
Number of subjects: 11
Study 30171747 — intervention group
Group type: COMPARATOR
Intervention: Low-dose metformin/linagliptin combination therapy (LMET + DPP4) 750 mg metformin + 5 mg linagliptin
Number of subjects: 11
Study 28462861 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week training intervention
Number of subjects: 214
Study 28462861 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in sport activities at baseline
Number of subjects: 214
Study 28462861 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated health
Number of subjects: 214
Study 28462861 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 214
Study 28462861 — intervention group
Group type: EXPERIMENTAL
Intervention: Low education (<10 years)
Number of subjects: 214
Study 28462861 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <50 years
Number of subjects: 214
Study 25882200 — intervention group
Group type: EXPERIMENTAL
Intervention: Video plus verbal feedback
Number of subjects: 32
Study 25882200 — intervention group
Group type: COMPARATOR
Intervention: Verbal feedback
Number of subjects: 32
Study 25882200 — intervention group
Group type: COMPARATOR
Intervention: Experiential feedback
Number of subjects: 32
Study 24132374 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse wave velocity (PWV) measurement
Number of subjects: 91
Study 24132374 — intervention group
Group type: EXPERIMENTAL
Intervention: High white matter hyperintensity (WMH) burden
Number of subjects: 91
Study 21712672 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose low-molecular weight heparin (LMWH)
Number of subjects: 75
Study 21712672 — intervention group
Group type: COMPARATOR
Intervention: Long compression stockings
Number of subjects: 75
Study 19291301 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose AS (25 mg)/AQ (67.5 mg)
Number of subjects: 750
Study 19291301 — intervention group
Group type: COMPARATOR
Intervention: Loose AS (50 mg) + AQ (153 mg)
Number of subjects: 750
Study 19291301 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 750
Study 19291301 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose AS/AQ
Number of subjects: 750
Study 19291301 — intervention group
Group type: COMPARATOR
Intervention: Loose AS+AQ
Number of subjects: 750
Study 17355631 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir treatment for 21 days
Number of subjects: 12
Study 17355631 — intervention group
Group type: COMPARATOR
Intervention: No antiviral treatment (Control)
Number of subjects: 12
Study 15386322 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-penetrating clips
Number of subjects: 98
Study 15386322 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 98
Study 11208219 — intervention group
Group type: EXPERIMENTAL
Intervention: Newspaper advertisements
Number of subjects: 138
Study 11208219 — intervention group
Group type: EXPERIMENTAL
Intervention: Community referrals
Number of subjects: 138
Study 11208219 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio advertisements
Number of subjects: 138
Study 11208219 — intervention group
Group type: COMPARATOR
Intervention: Public television
Number of subjects: 138
Study 11208219 — intervention group
Group type: COMPARATOR
Intervention: Local posters
Number of subjects: 138
Study 11208219 — intervention group
Group type: EXPERIMENTAL
Intervention: Community colleges
Number of subjects: 138
Study 11208219 — intervention group
Group type: EXPERIMENTAL
Intervention: Press releases
Number of subjects: 138
Study 11208219 — intervention group
Group type: EXPERIMENTAL
Intervention: Community electronic sign
Number of subjects: 138
Study 9689189 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipriflavone, 200 mg three times daily
Number of subjects: 56
Study 9689189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 8279371 — intervention group
Group type: EXPERIMENTAL
Intervention: Anistreplase (APSAC) 30 U/5 min
Number of subjects: 182
Study 8279371 — intervention group
Group type: COMPARATOR
Intervention: Alteplase (rt-PA) 100 mg/3 hours (adjusted for body weight < 65 kg)
Number of subjects: 182
Study 8279371 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (dose adjusted to maintain therapeutic partial thromboplastin time)
Number of subjects: 182
Study 2638321 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine-fortified ORS at a concentration of 111 mmol/L (8.4 g/L)
Number of subjects: 50
Study 2638321 — intervention group
Group type: COMPARATOR
Intervention: Standard WHO-ORS
Number of subjects: 50
Study 2638321 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine-fortified ORS
Number of subjects: 50
Study 1057645 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival curettage
Number of subjects: 82
Study 1057645 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap surgery
Number of subjects: 82
Study 1057645 — intervention group
Group type: COMPARATOR
Intervention: Pocket elimination
Number of subjects: 82
Study 1057645 — intervention group
Group type: COMPARATOR
Intervention: All methods
Number of subjects: 82
Study 30742834 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg MB‐MMX
Number of subjects: 1205
Study 30742834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1205
Study 30004915 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week RESTORE program (exercise training, dietary counseling, and multidisciplinary education)
Number of subjects: 43
Study 30004915 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 43
Study 27998849 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting nitinol stents (PES)
Number of subjects: 28
Study 27998849 — intervention group
Group type: COMPARATOR
Intervention: Bare metal nitinol stents (BMS)
Number of subjects: 28
Study 24673054 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with bloodletting
Number of subjects: 160
Study 24673054 — intervention group
Group type: COMPARATOR
Intervention: Loratadine (10 mg, once a day)
Number of subjects: 160
Study 22764339 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐wave laser irradiation (810 nm, 8 J/point)
Number of subjects: 125
Study 22764339 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐wave MLS laser irradiation (1100 mW, 2000 Hz, 12.4 J/point)
Number of subjects: 125
Study 22764339 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐wave MLS laser irradiation (dose 6.6 J/point)
Number of subjects: 125
Study 22764339 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (simulated laser therapy without actual irradiation)
Number of subjects: 125
Study 20395003 — intervention group
Group type: EXPERIMENTAL
Intervention: Braithwaite protocol
Number of subjects: 120
Study 20395003 — intervention group
Group type: COMPARATOR
Intervention: simple sliding scale
Number of subjects: 120
Study 17617942 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycaemic index (LGI) diet
Number of subjects: 38
Study 17617942 — intervention group
Group type: COMPARATOR
Intervention: High-glycaemic index (HGI) diet
Number of subjects: 38
Study 16214482 — intervention group
Group type: COMPARATOR
Intervention: Gastrocnemius-Soleus (GS) muscle force-angle relation in SCI subjects
Number of subjects: 20
Study 16214482 — intervention group
Group type: COMPARATOR
Intervention: Gastrocnemius-Soleus (GS) knee (GSK) force-angle measurements in SCI subjects
Number of subjects: 20
Study 16214482 — intervention group
Group type: COMPARATOR
Intervention: Tibialis Anterior (TA) muscle force-angle relation in SCI subjects
Number of subjects: 20
Study 16214482 — intervention group
Group type: COMPARATOR
Intervention: Range of motion (ROM) in dorsiflexion direction in SCI subjects
Number of subjects: 20
Study 16214482 — intervention group
Group type: COMPARATOR
Intervention: Range of motion (ROM) in plantar flexion direction in SCI subjects
Number of subjects: 20
Study 11849576 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 1 mg x ml(-1)
Number of subjects: 110
Study 11849576 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg x ml(-1)
Number of subjects: 110
Study 11849576 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 3 mg x ml(-1)
Number of subjects: 110
Study 11849576 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 110
Study 10745613 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen plugging with VasoSeal
Number of subjects: 150
Study 10745613 — intervention group
Group type: COMPARATOR
Intervention: Control group (manual compression)
Number of subjects: 150
Study 8775899 — intervention group
Group type: EXPERIMENTAL
Intervention: No. 8 silastic feeding tube for bladder drainage
Number of subjects: 146
Study 1974533 — intervention group
Group type: EXPERIMENTAL
Intervention: Falope ring
Number of subjects: 100
Study 1974533 — intervention group
Group type: EXPERIMENTAL
Intervention: Clip
Number of subjects: 100
Study 1974533 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomeroy ligation
Number of subjects: 100
Study 1974533 — intervention group
Group type: COMPARATOR
Intervention: Electrocoagulation
Number of subjects: 100